Pathology of Prostate Cancer: What Urologist Should Know and Future Directions

Author:

Singh Nikhil1,Rane Swapnil1,Menon Santosh1

Affiliation:

1. Department of Pathology, Tata Memorial Centre, Mumbai, Maharashtra, India

Abstract

Summary Prostate cancer is the second-most common malignancy in men. Risk factors include age, family history, and genetic predisposition. Gleason grading remains one of the strongest prognostic factors in prostate cancer which has been modified multiple times with the most recent modifications brought in ISUP 2019 consensus conference and by GUPS. This chapter aims to familiarize the urologist with the nuances of pathology reporting, especially the Gleason scoring system in a simplified manner with some practical updates. It also brings forth the latest upcoming trends in areas of the utility of artificial intelligence in the field of prostate pathology.

Publisher

Medknow

Reference9 articles.

1. Recent global patterns in prostate cancer incidence and mortality rates;Culp;Eur Urol,2020

2. The burden of cancers and their variations across the states of India: The global burden of disease study 1990-2016;Lancet Oncol,2018

3. Prostate pathology: What is new in the 2022 WHO classification of urinary and male genital tumors?;Surintrspanont;Pathologica,2022

4. Acontemporary prostate cancer grading system: A validated alternative to the Gleason score;Epstein;Eur Urol,2016

5. Prostate cancer: Update on grading and reporting;Baraban;Surg Pathol Clin,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3